赛夫迪托伦对细菌中的青素结合蛋白的亲和力及其与抗生素敏感性的关系
Yixin Qi1, Qixue Shi1, Lingman Ma1
1School of Life Science and Technology, China Pharmaceutical University, 639 Longmian Road, Nanjing, 211198, Jiangsu, China.
Archives of microbiology
|November 18, 2024
概括
第三代头素Cefditoren对Streptococcus pneumoniae和Haemophilus influenzae中的青素结合蛋白 (PBPs) 具有强烈的结合亲和力. 这种高亲和力可能解释了它对细菌感染的有效性和耐药性潜力较低.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 青素结合蛋白 (PBPs) 是β-乳酸抗生素的关键点.
- 对于抗生素的PBP亲和力变化显著影响细菌易感性.
- 了解 cefditoren 的结合机制是其治疗应用的关键.
研究的目的:
- 为了阐明 cefditoren 的结合机制,一个口服的第三代胞,到 PBPs.
- 评估 cefditoren 对关键细菌物种的抗菌活性和PBP结合亲和力.
主要方法:
- 使用最小抑制度 (MIC),杀菌曲线和抑制区比较,评估了抗菌活性.
- 从Streptococcus pneumoniae中纯化的PBP1A和PBP2X用于微尺度热泳结合试验.
- 采用生物化安培 (BIO-AMP) 方法来确定 cefditoren 与 Haemophilus influenzae PBPs 的亲和力.
主要成果:
- 塞夫迪托伦对Streptococcus pneumoniae的PBP1A表现出很高的亲和力 (Kd = 0.005 ± 0.004 μM),超过了其他旋素.
- 塞夫迪托伦对S. pneumoniae的PBP2X表现出中等的亲和力 (Kd = 9.70 ± 8.24 μM).
- 塞夫迪托伦对Haemophilus influenzae的PBP3A/B具有显著的结合 (IC50 = 0.060 ± 0.002μM).
结论:
- 塞夫迪托伦对S. pneumoniae中的PBP1A和H. influenzae中的PBP1A/PBP3A/B具有很强的亲和力.
- 这种高的PBP亲和力可能有助于赛夫迪托伦强大的抗菌作用和减少对抗药性发展的倾向.
- 这些发现为 cefditoren 的疗效提供了机制基础,并支持其在抗生素治疗中的使用.
相关概念视频
Factors Affecting Protein-Drug Binding: Drug-Related Factors
85
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
85
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
126
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
126
Antibiotic Selection
52.3K
Overview
52.3K
Antimicrobial Proteins
934
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
934


